- Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Burris, H.A., Calvert, S.W., Willcutt, N.T., Scullin, D.C., Bramham, J., Greco, F.A. Cancer Invest. (2001)